CAS RN: 99513-17-4
5-broMo-1,2-diMethyl-1H-benzo[d]iMidazole
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250705
250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 99513-17-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
99513-17-4 / 5-bromo-1,2-dimethylbenzimidazole
Standard CAS: 99513-17-4
Multi CAS: No
Basic Information
copy
CAS
99513-17-4 copy
Multi CAS
No copy
Molecular Formula
BC9H9Rn2 copy
Molecular Weight
225.080000 copy
Exact Mass
223.994910 copy
InChI
InChI=1S/C9H9BrN2/c1-6-11-8-5-7(10)3-4-9(8)12(6)2/h3-5H,1-2H3 copy
InChIKey
KXQPLXMYJLKDMW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.22 copy
H-bond acceptors
2 copy
Molar refractivity
53.15 copy
TPSA
17.82 copy
LogP / Solubility
WLOGP
2.64 copy
MLOGP
2.33 copy
XLogP3
2.5 copy
Consensus LogP
2.49 copy
Log S (ESOL)
-3.46 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.31 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.32 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.22 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy